Add to favorites

#Industry News

Contract signing ceremony of the Joint Laboratory for thrombosis

Joint Laboratory for thrombosis

Contract signing ceremony of "Joint Laboratory for thrombosis and hemostasis of Thistory Bio-Medical & Zhili Diagnosis" jointly built was held in Shenzhen, and the enterprise leaders of both parties attended the ceremony on January 6th, 2021.

Based on the principle of "long-term cooperation, equality, mutual benefit and consensus", both parties will give full play to their experience and resource advantages in the field of thrombosis and hemostasis, and realize mutual benefit, mutual construction of ecology and joint development.

Thistory Bio-Medical mainly focus on screening, diagnosis and prevention of thrombosis & hemostasis diseases, as well as cardiovascular and cerebrovascular diseases. The enterprise not only has the industry-leading patent technology reserve and layout, but also has profound resource accumulation and industrialization advantages in multi-directional industries. In addition, the enterprise has the strength of collaborative development of instrument system and reagent system, so as to achieve systematic product R&D in the real sense.

Zhili Diagnosis is a comprehensive professional medical service enterprise focusing on the screening, diagnosis and treatment of coagulation and anticoagulant diseases. Zhili Diagnosis has a top-level team of experts in the field of thrombosis and hemostasis and rich industry resources in the field of segmentation.

In the future, both parties will strive to build a perfect platform for diagnosis and treatment of thrombosis and hemostasis, and continue to deepen cooperation in innovation and development, product update, market expansion to build a win-win situation.

Contract signing ceremony of the Joint Laboratory for thrombosis

Details

  • China
  • Shenzhen Thistory Bio-Medical Co., Ltd